▲11月6-7日第十届广州(大湾区)生物医药创新者峰会扫码报名声明:因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及);本文不构成任何投资建议。10月10日,在首席执行官Maziar Mike Doustdar的重组计划下,诺和诺德将终止所有细胞疗法业务。作为此举的一部分,该公司将裁掉该部门近250名员工。新任首席执行官...
Source Link▲11月6-7日第十届广州(大湾区)生物医药创新者峰会扫码报名声明:因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及);本文不构成任何投资建议。10月10日,在首席执行官Maziar Mike Doustdar的重组计划下,诺和诺德将终止所有细胞疗法业务。作为此举的一部分,该公司将裁掉该部门近250名员工。新任首席执行官...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.